Literature DB >> 12480509

Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice.

Craig J Serpe1, Julie E Tetzlaff, Susanna Coers, Virginia M Sanders, Kathryn J Jones.   

Abstract

The goal of the current study was to determine if T and B lymphocytes play a role in functional recovery after peripheral nerve injury. The time course of behavioral recovery following facial nerve crush injury at the stylomastoid foramen was established in scid mice which lack functional T and B cells and reconstituted scid mice as compared to wild-type mice. The average time necessary for recovery of full eye blink reflex and vibrissae movements in wild-type mice was 10.3+/-0.2 and 9.9+/-0.34 days, respectively. In contrast, recovery of full eye blink reflex and vibrissae movements took 14.8+/-0.54 and 12.3+/-0.41 days, respectively, in scid mice. Reconstitution of scid mice with whole splenocytes resulted in functional recovery times similar to wild-type, with eye blink reflex recovery and vibrissae movement being 10.5+/-0.3 and 10.0+/-0.0 days, respectively. These results suggest that the delayed behavioral recovery time observed in scid mice may be due to the absence of T and B lymphocytes.

Entities:  

Mesh:

Year:  2002        PMID: 12480509     DOI: 10.1016/s0889-1591(02)00017-x

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  11 in total

Review 1.  Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction?

Authors:  N C Derecki; E Privman; J Kipnis
Journal:  Mol Psychiatry       Date:  2010-02-23       Impact factor: 15.992

2.  Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

Authors:  B D Armstrong; C Abad; S Chhith; G Cheung-Lau; O E Hajji; H Nobuta; J A Waschek
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

3.  Facial nerve axotomy in mice: a model to study motoneuron response to injury.

Authors:  Deborah N Olmstead; Nichole A Mesnard-Hoaglin; Richard J Batka; Melissa M Haulcomb; Whitney M Miller; Kathryn J Jones
Journal:  J Vis Exp       Date:  2015-02-23       Impact factor: 1.355

4.  Delayed functional recovery in presymptomatic mSOD1G93A mice following facial nerve crush axotomy.

Authors:  Nichole A Mesnard; Melissa M Haulcomb; Lisa Tanzer; Virginia M Sanders; Kathryn J Jones
Journal:  J Neurodegener Regen       Date:  2013

5.  T cell memory in the injured facial motor nucleus: relation to functional recovery following facial nerve crush.

Authors:  Grace K Ha; Marlon Pastrana; Zhi Huang; John M Petitto
Journal:  Neurosci Lett       Date:  2008-07-31       Impact factor: 3.046

6.  SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.

Authors:  Nichole A Mesnard-Hoaglin; Junping Xin; Melissa M Haulcomb; Richard J Batka; Virginia M Sanders; Kathryn J Jones
Journal:  Brain Behav Immun       Date:  2014-06-06       Impact factor: 7.217

7.  Functional recovery and facial motoneuron survival are influenced by immunodeficiency in crush-axotomized mice.

Authors:  Taylor Beahrs; Lisa Tanzer; Virginia M Sanders; Kathryn J Jones
Journal:  Exp Neurol       Date:  2009-11-11       Impact factor: 5.330

Review 8.  The Role of the IL-4 Signaling Pathway in Traumatic Nerve Injuries.

Authors:  John M Daines; Lauren Schellhardt; Matthew D Wood
Journal:  Neurorehabil Neural Repair       Date:  2021-03-23       Impact factor: 3.919

Review 9.  Role of immunity in recovery from a peripheral nerve injury.

Authors:  Virginia M Sanders; Kathryn J Jones
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

10.  Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.

Authors:  Junping Xin; Derek A Wainwright; Craig J Serpe; Virginia M Sanders; Kathryn J Jones
Journal:  Brain Behav Immun       Date:  2007-11-19       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.